The Clorox Company $CLX Shares Sold by Swedbank AB

Swedbank AB lowered its holdings in The Clorox Company (NYSE:CLX) by 60.6% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 75,890 shares of the company’s stock after selling 116,614 shares during the period. Swedbank AB owned about 0.06% of Clorox worth $9,357,000 at the end of the most recent quarter.

Several other institutional investors also recently made changes to their positions in CLX. DAVENPORT & Co LLC lifted its holdings in shares of Clorox by 11.2% in the 3rd quarter. DAVENPORT & Co LLC now owns 10,845 shares of the company’s stock worth $1,337,000 after purchasing an additional 1,091 shares during the last quarter. Yousif Capital Management LLC increased its position in Clorox by 1.0% in the third quarter. Yousif Capital Management LLC now owns 63,766 shares of the company’s stock worth $7,862,000 after buying an additional 605 shares during the period. Trust Co. of Vermont lifted its stake in Clorox by 6.4% in the third quarter. Trust Co. of Vermont now owns 22,123 shares of the company’s stock valued at $2,728,000 after buying an additional 1,321 shares during the last quarter. Patton Fund Management Inc. acquired a new position in shares of Clorox during the third quarter valued at $212,000. Finally, HBK Sorce Advisory LLC boosted its holdings in shares of Clorox by 19.7% during the third quarter. HBK Sorce Advisory LLC now owns 3,081 shares of the company’s stock valued at $368,000 after acquiring an additional 508 shares during the period. 78.53% of the stock is owned by institutional investors.

Analysts Set New Price Targets

CLX has been the topic of a number of analyst reports. Morgan Stanley dropped their price objective on shares of Clorox from $137.00 to $125.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 4th. Citigroup dropped their price target on shares of Clorox from $120.00 to $109.00 and set a “neutral” rating on the stock in a research note on Wednesday, December 17th. JPMorgan Chase & Co. cut their price target on Clorox from $127.00 to $120.00 and set a “neutral” rating on the stock in a report on Tuesday, November 4th. UBS Group set a $119.00 price objective on Clorox and gave the stock a “neutral” rating in a report on Tuesday, November 4th. Finally, Zacks Research upgraded Clorox from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 26th. One equities research analyst has rated the stock with a Buy rating, thirteen have given a Hold rating and four have assigned a Sell rating to the company. According to data from MarketBeat, Clorox has a consensus rating of “Reduce” and a consensus target price of $125.00.

Insider Buying and Selling

In other Clorox news, Director Pierre R. Breber purchased 4,000 shares of the business’s stock in a transaction on Friday, November 21st. The stock was bought at an average cost of $104.13 per share, with a total value of $416,520.00. Following the acquisition, the director owned 13,000 shares of the company’s stock, valued at $1,353,690. The trade was a 44.44% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 0.63% of the company’s stock.

Clorox Trading Up 0.4%

Clorox stock opened at $98.56 on Friday. The Clorox Company has a 12-month low of $96.66 and a 12-month high of $164.41. The company has a debt-to-equity ratio of 18.01, a current ratio of 0.76 and a quick ratio of 0.50. The stock has a market capitalization of $12.02 billion, a PE ratio of 15.47, a price-to-earnings-growth ratio of 0.49 and a beta of 0.57. The firm has a 50 day simple moving average of $105.80 and a 200-day simple moving average of $117.11.

Clorox (NYSE:CLX) last released its earnings results on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, topping analysts’ consensus estimates of $0.78 by $0.07. Clorox had a return on equity of 358.39% and a net margin of 11.68%.The firm had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. During the same period in the prior year, the firm posted $1.86 earnings per share. The firm’s revenue for the quarter was down 18.9% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. As a group, equities research analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 28th will be issued a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a yield of 5.0%. The ex-dividend date of this dividend is Wednesday, January 28th. Clorox’s payout ratio is presently 77.86%.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.